The ST-segment–elevation myocardial infarction chain of survival
JP Ornato - Circulation, 2007 - Am Heart Assoc
Circulation, 2007•Am Heart Assoc
The benefit of expertly performed, timely, primary percutaneous coronary intervention (PCI)
over fibrinolysis is clear for patients with ST-segment–elevation myocardial infarction
(STEMI). Primary PCI is superior to fibrinolysis for reduction of overall short-term mortality,
nonfatal reinfarction, stroke, and the combined end point of death, nonfatal reinfarction, and
stroke. 1 These results remain valid during long-term follow-up and are independent of both
the type of fibrinolytic used and whether the patient is transferred for primary PCI.
over fibrinolysis is clear for patients with ST-segment–elevation myocardial infarction
(STEMI). Primary PCI is superior to fibrinolysis for reduction of overall short-term mortality,
nonfatal reinfarction, stroke, and the combined end point of death, nonfatal reinfarction, and
stroke. 1 These results remain valid during long-term follow-up and are independent of both
the type of fibrinolytic used and whether the patient is transferred for primary PCI.
The benefit of expertly performed, timely, primary percutaneous coronary intervention (PCI) over fibrinolysis is clear for patients with ST-segment–elevation myocardial infarction (STEMI). Primary PCI is superior to fibrinolysis for reduction of overall short-term mortality, nonfatal reinfarction, stroke, and the combined end point of death, nonfatal reinfarction, and stroke. 1 These results remain valid during long-term follow-up and are independent of both the type of fibrinolytic used and whether the patient is transferred for primary PCI.
Am Heart Assoc
